Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
AXGN will pay $200 million in cash to acquire BioCircuit, adding NerveTape and an FDA-approved suture-less nerve repair device to its portfolio. The deal is expected to be accretive to revenue and EBITDA by 2027.
Axogen: Deal Adds NerveTape Device for Sutureless Peripheral Nerve Repair >AXGN